Important Disclosure

Midas Letter is financially supported in part by the provision of financial marketing services to publicly traded companies.

Any paid advertising issue of James West’s Midas Letter and Midas Letter Alerts does not purport to provide an analysis of any company’s financial position or prospects and any information supplied is not in any way to be construed as an offer or solicitation to buy or sell any security. Although the information contained in this website, email and other is believed to be reliable, Midas Letter and its editors make no warranties as to the accuracy of the description of any of the content herein and accept no liability for how readers may choose to use it. Midas Letter, including any of our principals, officers, directors, partners, agents, or affiliates are not, nor do we represent ourselves to be, registered investment advisors, brokers, or dealers in securities. Readers should independently verify all statements made in this website and all issues of its publication. Product names, logos, brands, and other trademarks featured or referred to within our publication are the property of their respective trademark holders. These trademark holders are not affiliated with Midas Letter.

This website, including any published material, and the opinions of those quoted within are for informational and advertising purposes only. Speculation in securities carries a high degree of risk, and investors purchasing speculative investments should be capable of absorbing losses of all of their invested capital. There is no assurance that any featured company will receive additional funding or experience any future development necessary for corporate success. Information contained in this website, including any published material contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements regarding the expected continual growth of the market for the company’s products, the company’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc. Midas Letter Premium Edition is distributed 12 times a year at a cost of $49 per month (or $499 per year). It is published on the first Sunday of each month, unless it’s a long weekend, in which case we publish the following Sunday. Midas Letter covers equities, yield products, and private placement opportunities for accredited investors in technology, consumer goods, energy, mining and biotechnology.

We seek to identify stocks that have strong fundamentals and with asymmetric risk-reward profiles. Subscribers and potential subscribers to the Midas Letter Premium Edition are cautioned that while companies are selected based on the quality of management, projects and capital structures, there is always the risk when investing that you could lose a substantial portion of or even your entire investment. The objective of the Midas Letter is to seek out publicly traded companies that West believes are most likely to succeed in their stated business objectives. West invests his own money in these companies and so all content in this newsletter should be viewed as biased and in all circumstances, the reader should consider that he has an interest in any company mentioned herein. James West stands to benefit financially whenever shares in the companies he features rise in price.

By reading James West’s Midas Letter and Midas Letter Alerts, you agree to hold James West’s Midas Letter, its associates, sponsors, affiliates, and partners harmless and to completely release them from any and all liabilities due to any and all losses, damages, or injuries (financial or otherwise) that may be incurred. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur. Past investment performance is not in any way indicative of future investment performance. Readers must consult with registered professional investment, taxation, and portfolio advisors before making an investment decision. Readers and members must also independently verify the “blue-sky” eligibility of any securities mentioned within this website, including any publication distributed. Further, specific financial information, filings and disclosures as well as general investor information about publicly listed companies and other investor resources can be found at the U.S. Securities and Exchange Commission website at, and/or in Canada at Sedar Filings website at

Where a fee has been paid or received by either of a third party or a company directly, the article or item shall bear the word “Sponsored” prominently at the top of the email or article, and a link to this information will be provided.

Midas Letter and James West also makes investments in companies featured at, and there are instances where the company will both sponsor advertising, and James West and/or Midas Letter Media Corp and/or its affiliated entities will also own shares in the company, or participate in option agreements to purchase shares at a future date and at a fixed price, or may have an option privately to purchase shares and/or warrants from an existing shareholder of the subject company.

Midas Letter and its affiliated entities reserve the right to participate in such compensation structures without further notice to readers beyond the disclosure that such participation exists in this document.


Free Newsletter,
Priceless Content.

Get more of Midas Letter delivered right to your inbox.

Special Offer

Sign-up today and receive free and immediate access to three recently published special reports!